New research has found that a variant of a drug used to treat pulmonary arterial hypertension prompts weight loss in obese mice. Among mice fed a high-fat diet, those who did not get the medication became obese while medicated ...
May 28, 2015
0
99
Health officials say fewer Americans are getting sick from a nasty germ sometimes found in undercooked hamburgers.
May 14, 2015
0
6
A new kind of immune therapy has shown promise against the third most common blood cancer, multiple myeloma, researchers said Wednesday.
May 13, 2015
0
6
The Food and Drug Administration is outlining its plan to end the nation's lifetime ban on blood donations from gay and bisexual men, a 32-year-old policy that many medical groups and gay activists say is no longer justified.
May 12, 2015
0
5
Young children in households with no financial restraints may be at risk for poor eating habits by watching television commercials about fast food, sugary drinks and salty snacks.
May 12, 2015
0
13
Federal health regulators have questions about the benefits of an experimental combination drug for cystic fibrosis developed by Vertex Pharmaceuticals, including whether the addition of a second drug ingredient adds to the ...
May 8, 2015
0
9
Blue Bell Creameries knew there was listeria in one of the company's plants as far back as March 2013, according to a government investigation. But the company didn't issue any recalls or shut down its production until after ...
May 7, 2015
0
7
The Food and Drug Administration will ask a group of outside medical experts next month to evaluate a much-debated experimental drug designed to boost sexual desire in women.
May 7, 2015
0
5
Highly priced cancer drugs get rushed approvals despite poor trial methodology and little effect on the longevity of patients, cautions York University Professor Dr. Joel Lexchin in the School of Health Policy and Management.
May 7, 2015
0
6
Alexion Pharmaceuticals will pay a huge premium to buy Synageva BioPharma in an $8.4-billion deal for a rare disease treatment maker that lost nearly $60 million in the first quarter and has no products on the market.
May 6, 2015
0
4
